SCHMERTZLER MICHAEL sold PTCT
September 17, 2026 · Form 4 insider transaction
SCHMERTZLER MICHAEL sold 376 shares of PTC Therapeutics, Inc. at $68.45 per share, a transaction worth $25.7K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by Section Six Partners, L.P., of which the Reporting Person is a general partner and limited partner, on May 14, 2026.; This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $68.35 to $68.84 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.